Cabaletta Bio
CABA
CABA
108 hedge funds and large institutions have $87.2M invested in Cabaletta Bio in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 25 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
-12
Holders Change %
-10%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
40
Reduced
25
Closed
37
Calls
$1.06M
Puts
$371K
Net Calls
+$684K
Net Calls Change
+$296K
Top Buyers
| 1 |
SCM
1
Superstring Capital Management
New York
|
$1.87M |
| 2 |
2
Morgan Stanley
New York
|
$3.27M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$2.87M |
| 4 |
4
Adage Capital Partners
Boston,
Massachusetts
|
$8.25M |
| 5 |
5
Two Sigma Advisers
New York
|
$1.89M |
Top Sellers
| 1 |
VA
1
VR Adviser
New York
|
$0 |
| 2 |
SI
2
Sofinnova Investments
Menlo Park,
California
|
$0 |
| 3 |
3
Jennison Associates
New York
|
$5.7M |
| 4 |
SC
4
Stempoint Capital
New York
|
$0 |
| 5 |
CC
5
Commodore Capital
New York
|
$0 |
